Can-Fite BioPharma Ltd. (CANF) stock
CANFNYSEPharmaceutical PreparationsFiscal year ends December 31
$1.51−0.02 (-1.31%)
Close on Nov 18, 2026Market cap $1.98MP/E –Yield –
Can-Fite BioPharma revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
For fiscal 2025 it was $405.00K, down 39.9% from the year before. Over ten years it grew 9.6% a year on average. The highest annual figure on record is $3.82M in fiscal 2018.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $405.00K | -39.9% |
| FY2024 | Dec 31, 2024 | $674.00K | -9.3% |
| FY2023 | Dec 31, 2023 | $743.00K | -8.3% |
| FY2022 | Dec 31, 2022 | $810.00K | -5.0% |
| FY2021 | Dec 31, 2021 | $853.00K | +11.8% |
| FY2020 | Dec 31, 2020 | $763.00K | -62.5% |
| FY2019 | Dec 31, 2019 | $2.03M | -46.8% |
| FY2018 | Dec 31, 2018 | $3.82M | +384.2% |
| FY2017 | Dec 31, 2017 | $789.00K | +378.2% |
| FY2016 | Dec 31, 2016 | $165.00K | +1.9% |
| FY2015 | Dec 31, 2015 | $162.00K | – |
See a number that looks wrong?